{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:08:21Z","timestamp":1771866501653,"version":"3.50.1"},"posted":{"date-parts":[[2025,11,18]]},"group-title":"In Review","reference-count":68,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,11,10]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by social deficits and stereotypic behaviors. Increased numbers of inflammatory cells and their mediators have been found in peripheral blood, brain, and gastrointestinal (GI) tissues of individuals with ASD. Regulatory T cells (Tregs) play a crucial role in suppressing inflammatory processes that, if disrupted, can result in inflammation and development of a variety of immunological conditions. In this study, we sought to characterize Tregs populations using flow cytometry and gene transcriptomic approaches in children with ASD (n\u2009=\u200936) and typically developing (TD) children (n\u2009=\u200918) enrolled in the Childhood Autism Risk from Genetics and Environment (CHARGE) study. We also examined differences in the frequencies of activated Tregs in ASD groups when stratified by co-occurring GI status. The frequency of gut homing \u03b14b7\n                  <sup>+<\/sup>\n                  Tregs positive for inhibitory receptors GITR, LAP, and\/or GARP were altered based on the presence of GI symptoms. Analysis of mRNA isolated from CD4\n                  <sup>+<\/sup>\n                  CD25\n                  <sup>+<\/sup>\n                  Tregs, showed 213 differentially expressed genes (DEGs) between the ASD and TD children. Upregulated DEGs were enriched in Gene Ontology (GO) Biological Processes involved in epigenetic regulation including 'chromatin organization', whereas Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were involved in metabolism, including 'lipid and atherosclerosis\u2019 and 'pantothenate and CoA biosynthesis'. Upregulation of immune signaling genes (MAPK3, JAK2, and CASP3) was also noted in the ASD Tregs. Downregulated DEGs consisted of genes enriched in immune terms including the GO term 'leukocyte differentiation' and KEGG pathways \u2018Parkinson disease\u2019 and 'protein processing in endoplasmic reticulum\u2019. Correlation analysis revealed a relationship between inappropriate speech scores and lower frequencies of Tregs in ASD children. Overall, these data support the hypothesis of altered Tregs cell biology in ASD, including their lower frequencies and altered gene expression. Furthermore, altered metabolic and immune signaling processes may contribute to changes in frequencies of Tregs in ASD based on co-morbidities, ultimately driving the immune status in ASD from a balanced to a dysregulated\/inflammatory state.\n                <\/p>","DOI":"10.21203\/rs.3.rs-8080761\/v1","type":"posted-content","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T16:43:43Z","timestamp":1763484223000},"source":"Crossref","is-referenced-by-count":0,"title":["Altered Phenotype and Gene Expression of Regulatory T cells (Tregs) in Children with Autism, and the Relationship with Comorbid Gastrointestinal Symptoms"],"prefix":"10.21203","author":[{"given":"Rachel J","family":"Moreno","sequence":"first","affiliation":[{"name":"UC Davis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Destanie","family":"Rose","sequence":"additional","affiliation":[{"name":"UC Davis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Ashwood","sequence":"additional","affiliation":[{"name":"UC Davis"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7202a1","article-title":"Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years \u2014 Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020","volume":"72","author":"Maenner MJ","year":"2023","unstructured":"Maenner MJ, et al. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years \u2014 Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020. MMWR Surveillance Summaries. 2023;72(2):1\u201314.","journal-title":"MMWR Surveillance Summaries"},{"key":"ref2","author":"Arenella M","year":"2021","unstructured":"Arenella M et al. Potential role for immune-related genes in autism spectrum disorders: Evidence from genome-wide association meta-analysis of autistic traits. Autism, 2021: p. 136236132110195."},{"key":"ref3","first-page":"43","article-title":"Dynamic Akt\/mTOR Signaling in Children with Autism Spectrum Disorder","volume":"5","author":"Onore C","year":"2017","unstructured":"Onore C, et al. Dynamic Akt\/mTOR Signaling in Children with Autism Spectrum Disorder. Front Pead. 2017;5:43.","journal-title":"Front Pead"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.3390\/ijms22105248","article-title":"Do Autism Spectrum and Autoimmune Disorders Share Predisposition Gene Signature Due to mTOR Signaling Pathway Controlling Expression?","volume":"22","author":"Trifonova EA","year":"2021","unstructured":"Trifonova EA, et al. Do Autism Spectrum and Autoimmune Disorders Share Predisposition Gene Signature Due to mTOR Signaling Pathway Controlling Expression? Int J Mol Sci. 2021;22(10):5248.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3390\/brainsci12081041","article-title":"Maternal Allergic Asthma Induces Prenatal Neuroinflammation","volume":"12","author":"Tamayo JM","year":"2022","unstructured":"Tamayo JM, et al. Maternal Allergic Asthma Induces Prenatal Neuroinflammation. Brain Sci. 2022;12(8):1041.","journal-title":"Brain Sci"},{"key":"ref6","article-title":"Maternal gut bacteria drive intestinal inflammation in offspring with neurodevelopmental disorders by altering the chromatin landscape of CD4+ T cells","author":"Kim E","year":"2021","unstructured":"Kim E et al. Maternal gut bacteria drive intestinal inflammation in offspring with neurodevelopmental disorders by altering the chromatin landscape of CD4+ T cells. Immunity, 2021.","journal-title":"Immunity"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41398-020-00976-2","article-title":"Maternal immune conditions are increased in males with autism spectrum disorders and are associated with behavioural and emotional but not cognitive co-morbidity","volume":"10","author":"Patel S","year":"2020","unstructured":"Patel S, et al. Maternal immune conditions are increased in males with autism spectrum disorders and are associated with behavioural and emotional but not cognitive co-morbidity. Translational Psychiatry. 2020;10(1):286.","journal-title":"Translational Psychiatry"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fncel.2018.00405","article-title":"Immune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders","volume":"12","author":"Hughes HK","year":"2018","unstructured":"Hughes HK, et al. Immune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders. Front Cell Neurosci. 2018;12:405.","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s10803-013-1973-x","article-title":"Gastrointestinal Problems in Children with Autism, Developmental Delays or Typical Development","volume":"44","author":"Chaidez V","year":"2014","unstructured":"Chaidez V, Hansen RL, Hertz-Picciotto I. Gastrointestinal Problems in Children with Autism, Developmental Delays or Typical Development. J Autism Dev Disord. 2014;44(5):1117\u201327.","journal-title":"J Autism Dev Disord"},{"key":"ref10","author":"Zerbo O","year":"2015","unstructured":"Zerbo O et al. Immune mediated conditions in autism spectrum disorders. Brain, Behavior, and Immunity, 2015. 46: pp. 232\u2013236."},{"key":"ref11","author":"Moreno RJ","year":"2025","unstructured":"Moreno RJ, Amara RA, Ashwood P. Toward a better understanding of T cell dysregulation in autism: An integrative review. Brain, Behavior, and Immunity, 2025. 123: pp. 1147\u20131158."},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13229-021-00472-4","article-title":"Regulatory T lymphocytes\/Th17 lymphocytes imbalance in autism spectrum disorders: evidence from a meta-analysis","volume":"12","author":"Ellul P","year":"2021","unstructured":"Ellul P, et al. Regulatory T lymphocytes\/Th17 lymphocytes imbalance in autism spectrum disorders: evidence from a meta-analysis. Mol Autism. 2021;12(1):68.","journal-title":"Mol Autism"},{"key":"ref13","author":"Rose DR","year":"2018","unstructured":"Rose DR et al. Differential immune responses and microbiota profiles in children with autism spectrum disorders and co-morbid gastrointestinal symptoms. Brain, Behavior, and Immunity, 2018. 70: pp. 354\u2013368."},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02276236","article-title":"Lymphocyte subsets and interleukin-2 receptors in autistic children","volume":"26","author":"Denney DR","year":"1996","unstructured":"Denney DR, Frei BW, Gaffney GR. Lymphocyte subsets and interleukin-2 receptors in autistic children. J Autism Dev Disord. 1996;26(1):87\u201397.","journal-title":"J Autism Dev Disord"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"100042","DOI":"10.1016\/j.bbih.2020.100042","article-title":"T cell populations in children with autism spectrum disorder and co-morbid gastrointestinal symptoms","volume":"2","author":"Rose DR","year":"2020","unstructured":"Rose DR, et al. T cell populations in children with autism spectrum disorder and co-morbid gastrointestinal symptoms. Behav Immun - Health. 2020;2:100042. Brain.","journal-title":"Behav Immun - Health"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.biopsych.2015.08.036","article-title":"Immune Endophenotypes in Children With Autism Spectrum Disorder","volume":"81","author":"Careaga M","year":"2017","unstructured":"Careaga M, et al. Immune Endophenotypes in Children With Autism Spectrum Disorder. Biol Psychiatry. 2017;81(5):434\u201341.","journal-title":"Biol Psychiatry"},{"key":"ref17","author":"Hughes HK","unstructured":"Hughes HK, R.J.Moreno, and, Ashwood P. Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD). Brain, Behavior, and Immunity, 2023. 108: pp. 245\u2013254."},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/biom15020207","article-title":"Altered Monocyte Populations and Activation Marker Expression in Children with Autism and Co-Occurring Gastrointestinal Symptoms","volume":"15","author":"Moreno RJ","year":"2025","unstructured":"Moreno RJ, et al. Altered Monocyte Populations and Activation Marker Expression in Children with Autism and Co-Occurring Gastrointestinal Symptoms. Biomolecules. 2025;15(2):207.","journal-title":"Biomolecules"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy S","year":"2023","unstructured":"Dikiy S, Rudensky AY. Principles of regulatory T cell function. Immunity. 2023;56(2):240\u201355.","journal-title":"Immunity"},{"issue":"1\u20132","key":"ref20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jneuroim.2008.07.006","article-title":"Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment in clinical behavioral outcomes","volume":"204","author":"Ashwood P","year":"2008","unstructured":"Ashwood P, et al. Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol. 2008;204(1\u20132):149\u201353.","journal-title":"J Neuroimmunol"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/brainsci9070152","article-title":"Rapid Communication: Plasma Interleukin-35 in Children with Autism","volume":"9","author":"Rose D","year":"2019","unstructured":"Rose D, Ashwood P. Rapid Communication: Plasma Interleukin-35 in Children with Autism. Brain Sci. 2019;9(7):152.","journal-title":"Brain Sci"},{"issue":"1\u20132","key":"ref22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jneuroim.2005.12.007","article-title":"Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms","volume":"173","author":"Ashwood P","year":"2006","unstructured":"Ashwood P, et al. Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J Neuroimmunol. 2006;173(1\u20132):126\u201334.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/08820139009041839","article-title":"Deficiency of Suppressor-Inducer (Cd4+Cd45ra+) T Cells in Autism","volume":"19","author":"Warren RP","year":"2009","unstructured":"Warren RP, et al. Deficiency of Suppressor-Inducer (Cd4+Cd45ra+) T Cells in Autism. Immunol Investig. 2009;19(3):245\u201351.","journal-title":"Immunol Investig"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/0883073809339393","article-title":"Frequency of CD4+CD25high Regulatory T Cells in the Peripheral Blood of Egyptian Children With Autism","volume":"25","author":"Mostafa GA","year":"2010","unstructured":"Mostafa GA, Shehab AA, Fouad NR. Frequency of CD4+CD25high Regulatory T Cells in the Peripheral Blood of Egyptian Children With Autism. J Child Neurol. 2010;25(3):328\u201335.","journal-title":"J Child Neurol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"102085","DOI":"10.1016\/j.rasd.2022.102085","article-title":"TH1\/Treg ratio may be a marker of autism in children with immune dysfunction","volume":"101","author":"Nie Z-Q","year":"2023","unstructured":"Nie Z-Q, et al. TH1\/Treg ratio may be a marker of autism in children with immune dysfunction. Res Autism Spectr Disorders. 2023;101:102085.","journal-title":"Res Autism Spectr Disorders"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/children8020116","article-title":"Dysregulation of Ki-67 Expression in T Cells of Children with Autism Spectrum Disorder","volume":"8","author":"Alhosaini K","year":"2021","unstructured":"Alhosaini K, et al. Dysregulation of Ki-67 Expression in T Cells of Children with Autism Spectrum Disorder. Children. 2021;8(2):116.","journal-title":"Children"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.gene.2016.10.019","article-title":"FOXP3 gene variations and susceptibility to autism: A case\u2013control study","volume":"596","author":"Safari MR","year":"2017","unstructured":"Safari MR, et al. FOXP3 gene variations and susceptibility to autism: A case\u2013control study. Gene. 2017;596:119\u201322.","journal-title":"Gene"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"939224","DOI":"10.3389\/fnmol.2022.939224","article-title":"Assessment of Expression of Regulatory T Cell Differentiation Genes in Autism Spectrum Disorder","volume":"15","author":"Akbari M","year":"2022","unstructured":"Akbari M, et al. Assessment of Expression of Regulatory T Cell Differentiation Genes in Autism Spectrum Disorder. Front Mol Neurosci. 2022;15:939224.","journal-title":"Front Mol Neurosci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fpsyt.2018.00627","article-title":"Anti-Candida albicans IgG Antibodies in Children With Autism Spectrum Disorders","volume":"9","author":"Hughes HK","year":"2018","unstructured":"Hughes HK, Ashwood P. Anti-Candida albicans IgG Antibodies in Children With Autism Spectrum Disorders. Front Psychiatry. 2018;9:627.","journal-title":"Front Psychiatry"},{"issue":"3","key":"ref30","first-page":"386","article-title":"The effects of sample size and variability on the correlation coefficient","volume":"28","author":"Bates B","year":"1996","unstructured":"Bates B, et al. The effects of sample size and variability on the correlation coefficient. Med Sci Sports Exerc. 1996;28(3):386\u201391.","journal-title":"Med Sci Sports Exerc"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1037\/met0000079","article-title":"Comparing the Pearson and Spearman Correlation Coefficients Across Distributions and Sample Sizes: A Tutorial Using Simulations and Empirical Data","volume":"21","author":"Winter JCF","year":"2016","unstructured":"Winter JCF, Gosling, Potter J. Comparing the Pearson and Spearman Correlation Coefficients Across Distributions and Sample Sizes: A Tutorial Using Simulations and Empirical Data. Psychol Methods. 2016;21(3):273\u201390.","journal-title":"Psychol Methods"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou Y","year":"2019","unstructured":"Zhou Y, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.","journal-title":"Nat Commun"},{"key":"ref33","first-page":"100042","volume-title":"T cell populations in children with autism spectrum disorder and co-morbid gastrointestinal symptoms","author":"Rose DR","year":"2020","unstructured":"Rose DR, et al. T cell populations in children with autism spectrum disorder and co-morbid gastrointestinal symptoms. Volume 2. Brain, Behavior, \\& Immunity - Health,; 2020. p. 100042."},{"key":"ref34","author":"Rose DR","year":"2018","unstructured":"Rose DR et al. Differential immune responses and microbiota profiles in children with autism spectrum disorders and co-morbid gastrointestinal symptoms. Brain, Behavior, and Immunity, 2018. 70: pp. 354\u2013368."},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/biomedicines11020436","article-title":"Preliminary Findings of Elevated Inflammatory Plasma Cytokines in Children with Autism Who Have Co-Morbid Gastrointestinal Symptoms","volume":"11","author":"Ashwood P","year":"2023","unstructured":"Ashwood P. Preliminary Findings of Elevated Inflammatory Plasma Cytokines in Children with Autism Who Have Co-Morbid Gastrointestinal Symptoms. Biomedicines. 2023;11(2):436.","journal-title":"Biomedicines"},{"key":"ref36","author":"Ashwood P","year":"2011","unstructured":"Ashwood P et al. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain, Behavior, and Immunity, 2011. 25(1): pp. 40\u201345."},{"issue":"1\u20132","key":"ref37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2008.12.002","article-title":"Elevated immune response in the brain of autistic patients","volume":"207","author":"Li X","year":"2009","unstructured":"Li X, et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol. 2009;207(1\u20132):111\u20136.","journal-title":"J Neuroimmunol"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s10875-004-6241-6","article-title":"Spontaneous Mucosal Lymphocyte Cytokine Profiles in Children with Autism and Gastrointestinal Symptoms: Mucosal Immune Activation and Reduced Counter Regulatory Interleukin-10","volume":"24","author":"Ashwood P","year":"2004","unstructured":"Ashwood P, et al. Spontaneous Mucosal Lymphocyte Cytokine Profiles in Children with Autism and Gastrointestinal Symptoms: Mucosal Immune Activation and Reduced Counter Regulatory Interleukin-10. J Clin Immunol. 2004;24(6):664\u201373.","journal-title":"J Clin Immunol"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"e19299","DOI":"10.1371\/journal.pone.0019299","article-title":"In Search of Cellular Immunophenotypes in the Blood of Children with Autism","volume":"6","author":"Ashwood P","year":"2011","unstructured":"Ashwood P, et al. In Search of Cellular Immunophenotypes in the Blood of Children with Autism. PLoS ONE. 2011;6(5):e19299.","journal-title":"PLoS ONE"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ana.25610","article-title":"T lymphocytes and cytotoxic astrocyte blebs correlate across autism brains","volume":"86","author":"DiStasio MM","year":"2019","unstructured":"DiStasio MM, et al. T lymphocytes and cytotoxic astrocyte blebs correlate across autism brains. Ann Neurol. 2019;86(6):885\u201398.","journal-title":"Ann Neurol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"577071","DOI":"10.1016\/j.jneuroim.2019.577071","article-title":"Th17\/Treg cells imbalance and their related cytokines (IL-17, IL-10 and TGF-\u03b2) in children with autism spectrum disorder","volume":"337","author":"Moaaz M","year":"2019","unstructured":"Moaaz M, et al. Th17\/Treg cells imbalance and their related cytokines (IL-17, IL-10 and TGF-\u03b2) in children with autism spectrum disorder. J Neuroimmunol. 2019;337:577071.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12031-016-0847-z","article-title":"Cytokine Profile in Autism Spectrum Disorders in Children","volume":"61","author":"Bryn V","year":"2017","unstructured":"Bryn V, et al. Cytokine Profile in Autism Spectrum Disorders in Children. J Mol Neurosci. 2017;61(1):1\u20137.","journal-title":"J Mol Neurosci"},{"issue":"1\u20132","key":"ref43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jneuroim.2008.07.006","article-title":"Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment in clinical behavioral outcomes","volume":"204","author":"Ashwood P","year":"2008","unstructured":"Ashwood P, et al. Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol. 2008;204(1\u20132):149\u201353.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01531729","article-title":"Immune abnormalities in patients with autism","volume":"16","author":"Warren RP","year":"1986","unstructured":"Warren RP, et al. Immune abnormalities in patients with autism. J Autism Dev Disord. 1986;16(2):189\u201397.","journal-title":"J Autism Dev Disord"},{"key":"ref45","author":"Ahmad SF","year":"2017","unstructured":"Ahmad SF et al. Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism. Molecular Neurobiology, 2017. 54(6): pp. 4390\u20134400."},{"key":"ref46","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pnpbp.2018.04.011","article-title":"Downregulation in Helios transcription factor signaling is associated with immune dysfunction in blood leukocytes of autistic children","volume":"85","author":"Ahmad SF","year":"2018","unstructured":"Ahmad SF, et al. Downregulation in Helios transcription factor signaling is associated with immune dysfunction in blood leukocytes of autistic children. Prog Neuropsychopharmacol Biol Psychiatry. 2018;85:98\u2013104.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"27","key":"ref47","doi-asserted-by":"crossref","first-page":"42826","DOI":"10.18632\/oncotarget.8753","article-title":"GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-\u03b2 releasing","volume":"7","author":"Sun L","year":"2016","unstructured":"Sun L, Jin H, Li H. GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-\u03b2 releasing. Oncotarget. 2016;7(27):42826\u201336.","journal-title":"Oncotarget"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.4049\/jimmunol.1300199","article-title":"Regulation of the Expression of GARP\/Latent TGF-\u03b21 Complexes on Mouse T Cells and Their Role in Regulatory T Cell and Th17 Differentiation","volume":"190","author":"Edwards JP","year":"2013","unstructured":"Edwards JP, et al. Regulation of the Expression of GARP\/Latent TGF-\u03b21 Complexes on Mouse T Cells and Their Role in Regulatory T Cell and Th17 Differentiation. J Immunol. 2013;190(11):5506\u201315.","journal-title":"J Immunol"},{"issue":"7","key":"ref49","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/s41423-021-00701-z","article-title":"Dysregulated immunity in PID patients with low GARP expression on Tregs due to mutations in LRRC32","volume":"18","author":"Lehmkuhl P","year":"2021","unstructured":"Lehmkuhl P, et al. Dysregulated immunity in PID patients with low GARP expression on Tregs due to mutations in LRRC32. Cell Mol Immunol. 2021;18(7):1677\u201391.","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI79014","article-title":"GP96 is a GARP chaperone and controls regulatory T cell functions","volume":"125","author":"Zhang Y","year":"2015","unstructured":"Zhang Y, et al. GP96 is a GARP chaperone and controls regulatory T cell functions. J Clin Invest. 2015;125(2):859\u201369.","journal-title":"J Clin Invest"},{"key":"ref51","author":"Tran DQ","year":"2009","unstructured":"Tran DQ et al. GARP (LRRC32) is essential for the surface expression of latent TGF-\u03b2 on platelets and activated FOXP3+ regulatory T cells. Proceedings of the National Academy of Sciences, 2009. 106(32): pp. 13445\u201313450."},{"key":"ref52","doi-asserted-by":"crossref","first-page":"588682","DOI":"10.3389\/fimmu.2020.588682","article-title":"The Role of GITR\/GITRL Interaction in Autoimmune Diseases","volume":"11","author":"Tian J","year":"2020","unstructured":"Tian J, et al. The Role of GITR\/GITRL Interaction in Autoimmune Diseases. Front Immunol. 2020;11:588682.","journal-title":"Front Immunol"},{"issue":"6","key":"ref53","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1615\/CritRevImmunol.v30.i6.40","article-title":"Role of the Glucocorticoid-Induced TNFR-Related Protein (GITR)-GITR Ligand Pathway in Innate and Adaptive Immunity","volume":"30","author":"Azuma M","year":"2010","unstructured":"Azuma M. Role of the Glucocorticoid-Induced TNFR-Related Protein (GITR)-GITR Ligand Pathway in Innate and Adaptive Immunity. Crit Rev Immunol. 2010;30(6):547\u201357.","journal-title":"Crit Rev Immunol"},{"issue":"5","key":"ref54","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s13075-014-0444-x","article-title":"Expansion of regulatory GITR+CD25low\/-CD4+ T cells in systemic lupus erythematosus patients","volume":"16","author":"Nocentini G","year":"2014","unstructured":"Nocentini G, et al. Expansion of regulatory GITR+CD25low\/-CD4+ T cells in systemic lupus erythematosus patients. Arthritis Res Therapy. 2014;16(5):444.","journal-title":"Arthritis Res Therapy"},{"key":"ref55","volume-title":"Low frequency of GITR+ T cells in ex vivo and in vitro expanded Treg cells from type 1 diabetic patients |","unstructured":"Low frequency of GITR+ T cells in ex vivo and in vitro expanded Treg cells from type 1 diabetic patients | International Immunology | Oxford Academic."},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ni759","article-title":"Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance","volume":"3","author":"Shimizu J","year":"2002","unstructured":"Shimizu J, et al. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol. 2002;3(2):135\u201342.","journal-title":"Nat Immunol"},{"issue":"9","key":"ref57","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1002\/eji.201343451","article-title":"Modulation of Treg cells\/T effector function by GITR signaling is context\u2013dependent","volume":"43","author":"Ephrem A","year":"2013","unstructured":"Ephrem A, et al. Modulation of Treg cells\/T effector function by GITR signaling is context\u2013dependent. Eur J Immunol. 2013;43(9):2421\u20139.","journal-title":"Eur J Immunol"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1038\/s41467-020-18761-6","article-title":"TASOR is a pseudo-PARP that directs HUSH complex assembly and epigenetic transposon control","volume":"11","author":"Douse CH","year":"2020","unstructured":"Douse CH, et al. TASOR is a pseudo-PARP that directs HUSH complex assembly and epigenetic transposon control. Nat Commun. 2020;11(1):4940.","journal-title":"Nat Commun"},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jaci.2023.12.001","article-title":"MYSM1 attenuates DNA damage signals triggered by physiologic and genotoxic DNA breaks","volume":"153","author":"Mathias B","year":"2024","unstructured":"Mathias B, et al. MYSM1 attenuates DNA damage signals triggered by physiologic and genotoxic DNA breaks. J Allergy Clin Immunol. 2024;153(4):1113\u2013e11247.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1006\/geno.2000.6311","article-title":"Functional Characterization of the Gene Encoding RLIM, the Corepressor of LIM Homeodomain Factors","volume":"69","author":"Ostendorff HP","year":"2000","unstructured":"Ostendorff HP, et al. Functional Characterization of the Gene Encoding RLIM, the Corepressor of LIM Homeodomain Factors. Genomics. 2000;69(1):120\u201330.","journal-title":"Genomics"},{"issue":"1","key":"ref61","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/s42003-023-05053-0","article-title":"SMCHD1 and LRIF1 converge at the FSHD-associated D4Z4 repeat and LRIF1 promoter yet display different modes of action","volume":"6","author":"\u0160ikrov\u00e1 D","year":"2023","unstructured":"\u0160ikrov\u00e1 D, et al. SMCHD1 and LRIF1 converge at the FSHD-associated D4Z4 repeat and LRIF1 promoter yet display different modes of action. Commun Biology. 2023;6(1):677.","journal-title":"Commun Biology"},{"issue":"3","key":"ref62","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2013.03.002","article-title":"Development and Maintenance of Regulatory T cells","volume":"38","author":"Ohkura N","year":"2013","unstructured":"Ohkura N, Kitagawa Y, Sakaguchi S. Development and Maintenance of Regulatory T cells. Immunity. 2013;38(3):414\u201323.","journal-title":"Immunity"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.3389\/fimmu.2019.02486","article-title":"Foxp3 Post-translational Modifications and Treg Suppressive Activity","volume":"10","author":"Deng G","year":"2019","unstructured":"Deng G, et al. Foxp3 Post-translational Modifications and Treg Suppressive Activity. Front Immunol. 2019;10:2486.","journal-title":"Front Immunol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"728783","DOI":"10.3389\/fimmu.2021.728783","article-title":"Metabolic Controls on Epigenetic Reprogramming in Regulatory T Cells","volume":"12","author":"Lu J","year":"2021","unstructured":"Lu J, et al. Metabolic Controls on Epigenetic Reprogramming in Regulatory T Cells. Front Immunol. 2021;12:728783.","journal-title":"Front Immunol"},{"issue":"10","key":"ref65","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s42255-020-00271-w","article-title":"Stable human regulatory T cells switch to glycolysis following TNF receptor 2 costimulation","volume":"2","author":"Kivit Sd","year":"2020","unstructured":"Kivit Sd, et al. Stable human regulatory T cells switch to glycolysis following TNF receptor 2 costimulation. Nat Metabolism. 2020;2(10):1046\u201361.","journal-title":"Nat Metabolism"},{"issue":"16","key":"ref66","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1016\/j.cell.2021.05.045","article-title":"Metabolic modeling of single Th17 cells reveals regulators of autoimmunity","volume":"184","author":"Wagner A","year":"2021","unstructured":"Wagner A, et al. Metabolic modeling of single Th17 cells reveals regulators of autoimmunity. Cell. 2021;184(16):4168\u2013e418521.","journal-title":"Cell"},{"issue":"11","key":"ref67","doi-asserted-by":"crossref","first-page":"e956","DOI":"10.1002\/mgg3.956","article-title":"Metformin treatment in young children with fragile X syndrome","volume":"7","author":"Biag HMB","year":"2019","unstructured":"Biag HMB, et al. Metformin treatment in young children with fragile X syndrome. Mol Genet Genom Med. 2019;7(11):e956.","journal-title":"Mol Genet Genom Med"},{"key":"ref68","first-page":"650","volume-title":"Novel potential of metformin on valproic acid-induced autism spectrum disorder in rats: involvement of antioxidant defence system","author":"Ishola IO","year":"2020","unstructured":"Ishola IO, Balogun AO, Adeyemi OO. Novel potential of metformin on valproic acid-induced autism spectrum disorder in rats: involvement of antioxidant defence system. Volume 34. Fundamental & Clinical Pharmacology; 2020. pp. 650\u201361. 6."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8080761\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8080761\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:14:03Z","timestamp":1771863243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8080761\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":68,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-8080761\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s12974-026-03701-w","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,11,18]]},"subtype":"preprint"}}